文献速递新发突发、热带与寄生虫病

少即是多?在评估RTS,S/AS01E疟疾疫苗影响时考虑分次剂量方案和不同疫苗剂次

Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine.
PubMed 文献 · J Infect Dis · 2024-01-01

该2b期试验在加纳和肯尼亚将1500名5-17月龄儿童随机分配接种RTS,S或狂犬病对照疫苗,评估全剂量与分次剂量方案。结果显示各RTS,S组临床疟疾疫苗效力相似,按全剂量当量计算分次剂量方案可节省剂量并提高影响。

要点

  • 各RTS,S组临床疟疾疫苗效力相似,范围38%至53%。
  • 按全剂量当量计算,分次剂量方案(Fx012-14-26和Fx017-20-32)的每千名接种儿童避免病例数高于全剂量方案。
  • 分次剂量方案可能是一种可行的节省剂量策略。

核心结论

  • 各RTS,S组的疫苗效力相似。
  • 考虑全剂量当量的疫苗影响表明,使用分次剂量方案可能是一种可行的节省剂量策略。
  • 如果这些观察结果维持至试验结束,则强调减少每剂方案成本从而最大化影响和优化供应的方法。

研究设计与样本

  • 2b期试验在加纳和肯尼亚开展,共1500名5-17月龄儿童按1:1:1:1:1随机分配接种RTS,S或狂犬病对照疫苗。
  • RTS,S组在第0和1月接种2剂全剂量RTS,S,随后接种全剂量(组R012-20、R012-14-26)或分次剂量(五分之一;组Fx012-14-26、Fx017-20-32)。

主要发现

  • 第1剂后第32个月,针对临床疟疾(所有发作)的疫苗效力范围从38%(R012-20;95%CI:24%-49%)到53%(R012-14-26;95%CI:42%-62%)。
  • 疫苗影响(每1000名接种儿童累计避免病例数)为:R012-20组1344,R012-14-26组2450,Fx012-14-26组2273,Fx017-20-32组2112。
  • 事后分析中,每1000剂RTS,S全剂量当量避免病例数为:R012-20组336,R012-14-26组490,Fx012-14-26组874,Fx017-20-32组880。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The RTS,S/AS01E (RTS,S) malaria vaccine is recommended for children in malaria endemic areas. This phase 2b trial evaluates RTS,S fractional- and full-dose regimens in Ghana and Kenya. METHODS: In total, 1500 children aged 5-17 months were randomized (1:1:1:1:1) to receive RTS,S or rabies control vaccine. RTS,S groups received 2 full RTS,S doses at months 0 and 1 and either full (groups R012-20, R012-14-26) or fractional doses (one-fifth; groups Fx012-14-26, Fx017-20-32). RESULTS: At month 32 post-dose 1, vaccine efficacy against clinical malaria (all episodes) ranged from 38% (R012-20; 95% confidence interval [CI]: 24%-49%) to 53% (R012-14-26; 95% CI: 42%-62%). Vaccine impact (cumulative number of cases averted/1000 children vaccinated) was 1344 (R012-20), 2450 (R012-14-26), 2273 (Fx012-14-26), and 2112 (Fx017-20-32). To account for differences in vaccine volume (fractional vs full dose; post hoc analysis), we estimated cases averted/1000 RTS,S full-dose equivalents: 336 (R012-20), 490 (R012-14-26), 874 (Fx012-14-26), and 880 (Fx017-20-32). CONCLUSIONS: Vaccine efficacy was similar across RTS,S groups. Vaccine impact accounting for full-dose equivalence suggests that using fractional-dose regimens could be a viable dose-sparing strategy. If maintained through trial end, these observations underscore the means to reduce cost per regimen thus maximizing impact and optimizing supply. CLINICAL TRIALS REGISTRATION: NCT03276962 (ClinicalTrials.gov).

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Westercamp N, Osei-Tutu L, Schuerman L, et al. Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine. J Infect Dis. 2024. PMID: 38438123. doi:10.1093/infdis/jiae075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。